G938-0132 Screening compound: N-(4-bromo-3-methylphenyl)-2-(N-methyl6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamido)acetamide

G938-0132 Screening compound: N-(4-bromo-3-methylphenyl)-2-(N-methyl6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamido)acetamide
G938-0132 Screening compound: N-(4-bromo-3-methylphenyl)-2-(N-methyl6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamido)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G938-0132
N-(4-bromo-3-methylphenyl)-2-(N-methyl6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamido)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G938-0132

Molecular Formula

C19H20BrN3O5S (C19 H20 BrN3 O5 S)

Compound Name

N-(4-bromo-3-methylphenyl)-2-(N-methyl6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamido)acetamide

IUPAC name

N-(4-bromo-3-methylphenyl)-2-(N-methyl6-methyl-3-oxo-34-dihydro-2H-14-benzoxazine-7-sulfonamido)acetamide

SMILES

Cc(cc(c(OC1)c2)NC1=O)c2S(N(C)CC(Nc(cc1)cc(C)c1Br)=O)(=O)=O

InChI

InChI=1S/C19H20BrN3O5S/c1-11-6-13(4-5-14(11)20)21-18(24)9-23(3)29(26,27)17-8-16-15(7-12(17)2)22-19(25)10-28-16/h4-8H,9-10H2,1-3H3,(H,21,24)(H,22,25)

InChI Key

BKIVVOLTLKGVAW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27168356

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.36

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.833

Distribution Coefficient, logD

2.833

Water Solubility, LogSw

-3.20

Polar Surface Area

89.222

Acid Dissociation Constant (pKa)

10.21

Base Dissociation Constant (pKb)

-1.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

G938-0132 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with G938-0132 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G938-0132?
Check Price and Availability of G938-0132, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G938-0132 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G938-0132
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G938-0132
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G938-0132 available by request